Proliferation is associated with 2-deoxy-d-[1-3H]glucose uptake by T47D breast turnour and SW480 and SW620 colonic tumour cells

Nuclear Medicine and Biology

Volumn 25, Issue 5, 1998, Pages 481-485

  Smith, Timothy A D ^a   Titley, Jennifer C ^b   McCready, V Ralph ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Deoxyglucose; Proliferation; Tumour cell lines

Indexed keywords

2 DEOXY DEXTRO [1 H3]GLUCOSE; DEOXYGLUCOSE; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; COLON TUMOR; DRUG UPTAKE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; ISOTOPE LABELING;

EID: 0032126508     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00014-6     Document Type: Article

References (20)

1. Baumann M., Jezussek D., Lang T., Richter R.T., Brand K. Activities of phosphohexose isomerase and other glycolytic enzymes in normal and tumor tissue of patients with neoplastic diseases Comparison with serum activities and correlation to tumor staging and grading . Tumour. Biol. 9:1988;281-286.
2. Brown R.S., Leung J.Y., Fisher S.J., Frey K.A., Ethier S.P., Wahl R.L. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma I. Are inflammatory cells important? J. Nucl. Med. 36:1995;1854-1861.
3. 18F]Fluoro-2-deoxy-D-glucose (FDG) in mammary tumors of antiestrogen-treated rats. Nucl. Med. Biol. 22:1995;483-489.
4. Haberkorn U., Ziegler S.I., Oberdorfer F., Trojan H., Dietrich H., Peschke P., et al. FDG uptake, tumor proliferation and expression of glycolysis-associated genes in animal tumor models. Nucl. Med. Biol. 21:1994;827-834.
5. Hawkins R. A., Hoh C.K. PET FDG studies in oncology. Nucl. Med. Biol. 21:1994;739-747.
6. Hoekstra O.S., Ossenkoppele G.J., Golding R. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. J. Nucl. Med. 34:1993;1706-1710.
7. Mineura K., Yashuda T., Kowada M., Ogawa T., Shishido F., Uemura K. Positron emission tomographic evaluation of radiochemotherapeutic effect of regional cerebral hemocirculation and metabolism in patients with gliomas. J. Neuroncol. 5:1987;277-285.
8. Minn H., Joensuu H., Ahonen A., Klemi P. Fluorodeoxyglucose imaging A method to assess the proliferative activity of human cancer in vivo . Cancer. 61:1988;1776-1781.
9. Minn H., Clavo A.C., Grenman R., Wahl R.L. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J. Nucl. Med. 36:1995;252-258.
10. Nagamatsu S., Nakamichi Y., Inoue N., Inoue M., Nishino H., Sawa H. Rat C6 glioma cell growth is related to glucose transport and metabolism. Biochem. J. 319:1996;477-482.
11. Reinhardt M.J., Kubota K., Yamada S., Iwata R., Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy A comparison of fluorodeoxyglucose, L-methionine and thymidine . J. Nucl. Med. 38:1997;280-287.
12. 11C]deoxyglucose . J. Cereb. Blood Flow Metab. 5:1985;179-192.
13. Smith T.A.D., Titley J., Eccles S.A., Court W. and McCready V.R. (1997) The relationship between deoxyglucose uptake and the growth rate of tumors in vitro. J. Nucl. Med. 38, 1046 (Abstract).
14. Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J. Nucl. Med. 32:1991;623-648.
15. Wahl R.L., Zasadny K.R., Hutchins G.D., Weber M., Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography (PET) Initial evaluation . J. Clin. Oncol. 11:1993;2101-2111.
16. Wahl R.L., Hawkins R.A., Larson S.M., Hendee W.R., Coleman R.E., Holden R.W., et al. Proceedings of a National Cancer Institute Workshop PET in oncology - a clinical research agenda . Radiology. 193:1994;604-606.
17. Watanabe A., Tanaka R., Takeda N., Washiyama K. DNA synthesis, blood flow, and glucose utilization in experimental rat tumors. J. Neurosurg. 70:1989;86-91.
18. Wienhouse S. (1976) The Warburg hypothesis fifty years later Z. Krebsforsch. 87, 115-126 (Guest editorial).
19. Yamamoto T., Seino Y., Fukumoto H., Koh G., Yano H., Inagaki N., et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170:1990;223-230.
20. Younes M., Brown R.W., Mody D.R., Fernandez L., Laucirica R. Glut1 expression in human breast carcinoma Correlation with known prognostic markers . Anticancer Res. 15:1995;2895-2898.